caseins has been researched along with deferasirox in 1 studies
| Studies (caseins) | Trials (caseins) | Recent Studies (post-2010) (caseins) | Studies (deferasirox) | Trials (deferasirox) | Recent Studies (post-2010) (deferasirox) |
|---|---|---|---|---|---|
| 16,863 | 561 | 4,170 | 832 | 136 | 572 |
| Protein | Taxonomy | caseins (IC50) | deferasirox (IC50) |
|---|---|---|---|
| Lysine-specific demethylase 6B | Homo sapiens (human) | 3.95 | |
| Lysine-specific demethylase 4A | Homo sapiens (human) | 3.77 | |
| Lysine-specific demethylase 5A | Homo sapiens (human) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adel, RM; Amer, AS; Darwish, AS; Lotfy, RA | 1 |
1 other study(ies) available for caseins and deferasirox
| Article | Year |
|---|---|
Destructive effect of iron overload in brain tissue of albino rats: Ameliorative role of silver immobilized organo-modified casein nanocomposite as co-treating agent with Deferasirox.
Topics: Animals; Antioxidants; Brain; Caseins; Deferasirox; Follicle Stimulating Hormone; Humans; Iron; Iron Chelating Agents; Iron Overload; Male; Metal Nanoparticles; Nanocomposites; Pharmaceutical Preparations; Rats; Silver | 2021 |